Natus Medical Incorporated, commonly referred to as Natus, is a leading provider of medical devices and services headquartered in the United States. Founded in 1989, the company has established a strong presence in the neurodiagnostic, newborn care, and hearing screening sectors, serving healthcare professionals across North America and globally. Natus is renowned for its innovative products, including advanced neurodiagnostic systems, neonatal monitoring solutions, and audiology equipment, which are designed to enhance patient care and improve clinical outcomes. The company’s commitment to quality and technological advancement has positioned it as a trusted partner in the medical community. With a focus on delivering exceptional value, Natus has achieved significant milestones, including numerous industry awards and recognitions, solidifying its status as a key player in the medical technology landscape.
How does Natus Medical Incorporated's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Natus Medical Incorporated's score of 17 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Natus Medical Incorporated reported a carbon footprint intensity of approximately 0.004 kg CO2e per unit of revenue, with no specific emissions data disclosed for Scope 1, 2, or 3. For 2024, the carbon footprint intensity increased to about 0.007 kg CO2e per unit of revenue. The company has not set any documented reduction targets or commitments to the Science Based Targets initiative (SBTi) and does not appear to have any significant climate pledges in place. As of now, Natus Medical Incorporated does not inherit emissions data from any parent or related organisations, indicating that their climate impact reporting is independent. The absence of specific emissions figures suggests a need for enhanced transparency and commitment to climate action within the medical technology sector.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Natus Medical Incorporated is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.